PDF] BCDB ‐ A database for breast cancer research and information
4.6 (686) · $ 25.99 · In stock
![PDF] BCDB ‐ A database for breast cancer research and information](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/72a3213d8bd899087817ce5deed75316ae463d1d/3-Figure2-1.png)
Frontiers Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment
Ki67 increase after core needle biopsy associated with worse disease outcome in HER2-negative breast cancer patients
Metabolites, Free Full-Text
Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis - Wu - Gland Surgery
PDF) Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses
PDF) Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2− Early Breast Cancer Patients
Frontiers Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast Cancer
PDF) Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis
Association of tumor immune microenvironment profiling and 21-gene recurrence assay in early breast cancer patients, European Journal of Medical Research
Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression, BMC Cancer
Frontiers Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients
Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy
